Add Company
Join Now

Penrose TherapeuTx Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Penrose TherapeuTx's estimated annual revenue is currently $2.4M per year.(i)
  • Penrose TherapeuTx's estimated revenue per employee is $301,500

Employee Data

  • Penrose TherapeuTx has 8 Employees.(i)
  • Penrose TherapeuTx grew their employee count by -20% last year.

Penrose TherapeuTx's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Research Scientist IReveal Email/Phone
5
Principal Scientist, Analytical ChemistryReveal Email/Phone
6
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$67.1M34320%$10.8MN/A
#2
$7.8M31-3%N/AN/A
#3
$5M2729%N/AN/A
#4
N/A814%N/AN/A
#5
$12.7M49-6%N/AN/A
#6
$16.5M737%N/AN/A
#7
$59.5M2967%N/AN/A
#8
$96.2M34229%$764.2MN/A
#9
$6.8M307%N/AN/A
#10
$5.4M235%N/AN/A
Add Company

What Is Penrose TherapeuTx?

Penrose TherapeuTx is a U.S.-based pharmaceutical company focused on developing innovative small-molecule therapies for the treatment of advanced cancers. Penrose has pioneered the development of a novel Mitochondrial Modifying Agent (MMA) therapeutic platform designed to generate therapies for difficult to treat cancers through a unique cooperative mechanism of action. Our approach has potential broad applicability across both hematologic and solid tumors.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$2.4M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M929%N/A
#2
$1.2M9-31%N/A
#3
N/A913%N/A
#4
$0.9M100%N/A
#5
$2.4M10-17%N/A